NASDAQ: MLYSMineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?
Insider buying vs selling
Have Mineralys Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jon Congleton | Chief Executive Officer | 2025-11-21 | 24,082 | $0.54 | $13.00kBuy |
| Brian Taylor Slingsby | Director | 2025-11-20 | 1,000,000 | $43.35 | $43.35MSell |
| Alexander M. Gold | Director | 2025-11-13 | 10,000 | $12.69 | $126.90kBuy |
| Daphne Karydas | Director | 2025-11-13 | 4,885 | $46.36 | $226.44kSell |
| Daphne Karydas | Director | 2025-11-13 | 10,115 | $45.81 | $463.35kSell |
| Alexander M. Gold | Director | 2025-11-13 | 12,742 | $46.50 | $592.50kSell |
| Alexander M. Gold | Director | 2025-11-13 | 2,742 | $10.20 | $27.97kBuy |
| Daphne Karydas | Director | 2025-11-13 | 15,000 | $10.20 | $153.00kBuy |
| Alexander M. Gold | Director | 2025-11-12 | 1,933 | $47.28 | $91.39kSell |
| Alexander M. Gold | Director | 2025-11-12 | 6,933 | $10.20 | $70.72kBuy |
MLYS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MLYS insiders and whales buy or sell their stock.
MLYS Shareholders
What type of owners hold Mineralys Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Srinivas Akkaraju | 14.33% | 11,338,067 | $410.44M | Insider |
| Samsara Biocapital GP LLC | 13.58% | 10,749,832 | $389.14M | Insider |
| Catalys Pacific LLC | 11.25% | 8,903,838 | $322.32M | Institution |
| Brian Taylor Slingsby | 9.99% | 7,903,838 | $286.12M | Insider |
| Ra Capital Management LP | 9.25% | 7,323,750 | $265.12M | Institution |
| Samsara Biocapital LLC | 7.91% | 6,263,151 | $226.73M | Institution |
| Ra Capital Management LP | 4.72% | 3,734,458 | $135.19M | Insider |
| Blackrock Inc | 4.64% | 3,671,614 | $132.91M | Institution |
| Hbm Healthcare Investments Cayman Ltd | 4.07% | 3,218,106 | $116.50M | Insider |
| Vanguard Group Inc | 3.81% | 3,018,999 | $109.29M | Institution |
MLYS vs Biotech Stocks
Mineralys Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.